Welcome to Multibagg AI
Log in to access personalized features
Discovery themes featuring this stock
Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.
Dashboard
Portfolio
Ask Iris
Discovery
Timeline
Multibagg AI is an AI powered stock research and analysis platform. We provide data, information, content, and analytics for publicly traded Indian companies listed on NSE and BSE. AI can make mistakes, check important information.
Prices might be delayed by a few minutes.
Join our Exclusive Community
Join our Exclusive Community
Made with 💙 in India. © Finsky Technologies Pvt Ltd. 2026
Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.
Choksi Laboratories Ltd (CHOKSILA) is currently trading at 99.10 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.
Choksi Laboratories Limited specializes in contract testing and analytical services, offering a wide range of consulting and laboratory solutions to various industries. The company supports over 1000 product analyses and continually expands its service offerings. This vast range reflects a robust capability to cater to diverse industrial needs. Renowned for its expertise, CLL provides precise calibration services aligned with national and international standards, vital for quality management and reducing defects. Strategically located laboratories across India, including facilities in Gujarat, Chandigarh, Goa, and Bangalore, underline the company’s operational reach and expansion history. Strategic registrations and evolving collaborations reinforce its reputation as a partner in regulatory compliance and quality assurance across sectors including pharmaceuticals and food.
Over the past 52 weeks, Choksi Laboratories Ltd has traded between a low of ₹81.85 and a high of ₹236.70. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.
Choksi Laboratories Ltd has a market capitalization of approximately 70.11. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.
Choksi Laboratories Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 37.69 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.
Based on its market capitalization of 70.11 Cr, Choksi Laboratories Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.
Choksi Laboratories Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.
The Price-to-Earnings (PE) ratio of Choksi Laboratories Ltd is 37.69. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.
Postal Ballot Result
Members approved the special resolution to appoint Mr. Ritik Pavecha (DIN: 08790431) as Non-Executive Independent Director via postal ballot/e‑voting; 1,444,392 votes in favour (100% of votes polled) on April 26, 2026.
Director Appointment
Choksi Laboratories shareholders approved by postal ballot (deemed passed on 26-Apr-2026) the special resolution to appoint Mr. Ritik Pavecha as Non‑Executive Independent Director; 1,444,392 votes cast (65.87% turnout), all in favor.
Bearish
4
Neutral
6
Bullish
4
Bearish
35
Neutral
6
Bullish
5
Bearish
31
Neutral
0
Bullish
1
Choksi Laboratories Limited specializes in contract testing and analytical services, offering a wide range of consulting and laboratory solutions to various industries.
The company supports over 1000 product analyses and continually expands its service offerings. This vast range reflects a robust capability to cater to diverse industrial needs.
Renowned for its expertise, CLL provides precise calibration services aligned with national and international standards, vital for quality management and reducing defects.
Strategically located laboratories across India, including facilities in Gujarat, Chandigarh, Goa, and Bangalore, underline the company’s operational reach and expansion history.
Strategic registrations and evolving collaborations reinforce its reputation as a partner in regulatory compliance and quality assurance across sectors including pharmaceuticals and food.
Healthcare Services
Healthcare Service Provider
70 Cr
Low Risk
37.7
56.7
0.5
2.9
236.70
81.85
Sales CAGR
Profit CAGR
ROE
ROCE
| Symbol | Watchlist | Price | Market Cap | P/E | P/B | Div Yield (%) | ROE (%) | ROCE (%) | ROA (%) |
99.85 | 70 Cr | 37.69 | 2.86 | 0.00 | 6.75 | 9.64 | 2.85 | ||
57.01 | 65 Cr | 27.23 | 9.03 | 0.00 | 16.62 | 13.17 | 13.75 | ||
29.50 | 49 Cr | 125.15 | 1.97 | 0.25 | 1.57 | 4.13 | 1.44 | ||
129.00 | 45 Cr | -32.54 | 1.16 | 0.00 | 12.51 | 14.95 | -3.23 | ||
17.08 | 39 Cr | -5.18 | 2.54 | 0.00 | -29.86 | -30.51 | -47.38 | ||
101.95 | 34 Cr | 28.39 | 2.76 | 0.00 | 9.84 | 10.99 | 3.78 | ||
15.44 | 32 Cr | 23.65 | 1.22 | 0.00 | 6.34 | 9.29 | 4.08 | ||
| Median: 7 Co. | — | 57.01 | 45 Cr | 27.23 | 2.54 | 0.00 | 6.75 | 9.64 | 2.85 |
